D-1442-2019 Class II Terminated
FDA drug recall D-1442-2019 was initiated by Zydus Pharmaceuticals USA Inc on May 6, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. The recall status is terminated (terminated Sep 16, 2021). Affected quantity: 204 1000-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- May 6, 2019
- Termination Date
- Sep 16, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 204 1000-count bottles
Product description
Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Distribution pattern
Nationwide in the USA
Code information
Lot: M714919, EXP Dec-19, M815081, EXP Aug-20, M900475, EXP Dec-20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1442-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026